| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Jan 08, 2024 | Sale | $28.87 | 2,275 | 65,682 | 44,594 | Jan 10, 2024, 04:15 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Jan 03, 2024 | Sale | $29.46 | 19,223 | 566,310 | 846,486 | Jan 05, 2024, 04:51 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Jan 03, 2024 | Sale | $29.46 | 5,843 | 172,135 | 54,372 | Jan 05, 2024, 04:50 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Jan 03, 2024 | Sale | $29.46 | 5,532 | 162,973 | 46,202 | Jan 05, 2024, 04:50 PM | |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | Jan 03, 2024 | Sale | $29.46 | 5,365 | 158,053 | 40,585 | Jan 05, 2024, 04:49 PM | |
| NTLA | Intellia Therapeutics, Inc. | Hicks Derek | EVP, Chief Business Officer | Jan 03, 2024 | Sale | $29.46 | 3,877 | 114,216 | 36,987 | Jan 05, 2024, 04:46 PM | |
| NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | Jan 03, 2024 | Sale | $29.46 | 3,805 | 112,095 | 51,474 | Jan 05, 2024, 04:45 PM | |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | Jan 03, 2024 | Sale | $29.50 | 4,608 | 135,954 | 45,146 | Jan 05, 2024, 04:44 PM | |
| NTLA | Intellia Therapeutics, Inc. | Bhanji Muna | Director | Oct 31, 2023 | Sale | $23.90 | 265 | 6,333 | 11,996 | Nov 02, 2023, 04:42 PM | |
| NTLA | Intellia Therapeutics, Inc. | Bhanji Muna | Director | Jul 31, 2023 | Sale | $42.33 | 265 | 11,217 | 12,261 | Aug 02, 2023, 05:19 PM | |
| NTLA | Intellia Therapeutics, Inc. | Bhanji Muna | Director | Jul 06, 2023 | Sale | $39.30 | 1,867 | 73,373 | 12,526 | Jul 10, 2023, 05:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | Jul 03, 2023 | Sale | $40.51 | 360 | 14,584 | 45,146 | Jul 06, 2023, 03:34 PM | |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | Jun 20, 2023 | Sale | $28.64 | 10,000 | 286,350 | 50,146 | Jun 22, 2023, 05:52 PM | |
| NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | Mar 02, 2023 | Sale | $43.88 | 1,088 | 47,741 | 55,279 | Mar 03, 2023, 05:10 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Jan 04, 2023 | Sale | $37.21 | 2,508 | 93,323 | 19,959 | Jan 06, 2023, 05:39 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Jan 05, 2023 | Sale | $38.48 | 2,330 | 89,659 | 18,318 | Jan 06, 2023, 05:39 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Jan 04, 2023 | Sale | $37.21 | 6,673 | 248,302 | 766,825 | Jan 06, 2023, 05:32 PM | |
| NTLA | Intellia Therapeutics, Inc. | Hicks Derek | EVP, Chief Business Officer | Jan 04, 2023 | Sale | $37.21 | 1,812 | 67,425 | 17,306 | Jan 06, 2023, 05:29 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Jan 04, 2023 | Sale | $37.21 | 2,574 | 95,779 | 25,687 | Jan 06, 2023, 05:26 PM | |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | Jan 04, 2023 | Sale | $37.21 | 2,427 | 90,309 | 15,404 | Jan 06, 2023, 05:23 PM | |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | Jan 04, 2023 | Sale | $37.21 | 1,692 | 62,959 | 14,473 | Jan 06, 2023, 05:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | Jul 01, 2022 | Sale | $51.74 | 105 | 5,433 | 16,165 | Jan 06, 2023, 05:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | Jan 03, 2023 | Sale | $34.48 | 231 | 7,965 | 16,165 | Jan 06, 2023, 05:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | Jan 04, 2023 | Sale | $37.21 | 1,138 | 42,345 | 19,559 | Jan 06, 2023, 05:19 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Jan 01, 2022 | Sale | $112.25 | 2,493 | 279,852 | 724,660 | Mar 04, 2022, 09:07 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Jan 01, 2022 | Sale | $112.25 | 1,148 | 128,863 | 4,815 | Mar 03, 2022, 08:03 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Jan 01, 2022 | Sale | $112.24 | 1,051 | 117,964 | 10,922 | Mar 03, 2022, 08:00 PM | |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | Jan 01, 2022 | Sale | $112.24 | 1,013 | 113,699 | 2,049 | Mar 03, 2022, 07:38 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Nov 05, 2021 | Sale | $72.67 | 4,800 | 348,823 | 11,114 | Nov 09, 2021, 06:08 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Oct 14, 2021 | Sale | $70.53 | 4,800 | 338,537 | 11,114 | Oct 15, 2021, 07:02 PM | |
| NTLA | Intellia Therapeutics, Inc. | Crowley John F | Director | Oct 11, 2021 | Option Exercise | $69.19 | 5,000 | 345,950 | 4,594 | Oct 13, 2021, 04:15 PM | |
| NTLA | Intellia Therapeutics, Inc. | Crowley John F | Director | Oct 05, 2021 | Sale | $74.68 | 20,000 | 1,493,691 | 12,094 | Oct 07, 2021, 05:41 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Sep 24, 2021 | Option Exercise | $12.62 | 7,923 | 99,988 | 8,714 | Sep 27, 2021, 04:15 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Sep 21, 2021 | Sale | $81.21 | 4,800 | 389,832 | 3,191 | Sep 23, 2021, 05:48 PM | |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | Sep 07, 2021 | Sale | $97.35 | 6,964 | 677,945 | 3,482 | Sep 09, 2021, 05:38 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Sep 01, 2021 | Sale | $95.81 | 89,470 | 8,571,950 | 764,040 | Sep 01, 2021, 08:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 30, 2021 | Sale | $85.09 | 77,608 | 6,603,384 | 758,109 | Sep 01, 2021, 08:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 31, 2021 | Sale | $84.79 | 75,666 | 6,415,720 | 757,138 | Sep 01, 2021, 08:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Aug 30, 2021 | Sale | $84.42 | 194,000 | 16,377,354 | 99,391 | Sep 01, 2021, 07:34 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Aug 30, 2021 | Option Exercise | $85.33 | 4,800 | 409,588 | 3,191 | Sep 01, 2021, 07:32 PM | |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | Aug 30, 2021 | Sale | $87.53 | 10,400 | 910,286 | 5,200 | Sep 01, 2021, 07:30 PM | |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | Aug 31, 2021 | Option Exercise | $89.57 | 49,600 | 4,442,830 | 24,800 | Sep 01, 2021, 07:30 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 23, 2021 | Sale | $82.71 | 54,278 | 4,489,079 | 746,444 | Aug 25, 2021, 04:14 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 19, 2021 | Sale | $82.34 | 45,364 | 3,735,337 | 741,987 | Aug 20, 2021, 06:14 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Aug 09, 2021 | Sale | $88.34 | 4,800 | 424,008 | 3,191 | Aug 11, 2021, 04:50 PM | |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | Aug 04, 2021 | Sale | $75.82 | 52,000 | 3,942,757 | 28,391 | Aug 06, 2021, 06:19 PM | |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | Aug 05, 2021 | Sale | $85.16 | 40,000 | 3,406,456 | 20,000 | Aug 06, 2021, 06:17 PM | |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Director | Apr 29, 2021 | Sale | $85.43 | 4,513 | 385,546 | 765,101 | Apr 30, 2021, 08:55 PM | |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Director | Apr 26, 2021 | Sale | $84.93 | 806 | 68,454 | 1,111,770 | Apr 28, 2021, 07:51 PM | |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Director | Apr 27, 2021 | Sale | $86.22 | 210,230 | 18,125,992 | 1,032,056 | Apr 28, 2021, 07:51 PM | |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Director | Apr 28, 2021 | Sale | $85.56 | 131,926 | 11,287,893 | 799,354 | Apr 28, 2021, 07:51 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Apr 13, 2021 | Option Exercise | $11.16 | 25,937 | 289,506 | 719,305 | Apr 15, 2021, 08:50 PM | |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Director | Apr 05, 2021 | Sale | $84.98 | 800 | 67,984 | 1,112,576 | Apr 07, 2021, 02:14 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Apr 01, 2021 | Sale | $36.45 | 147,456 | 5,374,096 | 178,077 | Apr 02, 2021, 08:42 PM | |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Director | Feb 26, 2021 | Sale | $60.29 | 501,945 | 30,262,716 | 1,113,376 | Mar 01, 2021, 01:59 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Feb 09, 2021 | Option Exercise | $38.35 | 32,489 | 1,245,870 | 129,409 | Feb 09, 2021, 08:38 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 05, 2021 | Sale | $33.18 | 62,942 | 2,088,185 | 654,803 | Feb 09, 2021, 08:36 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 09, 2021 | Option Exercise | $29.38 | 84,761 | 2,490,609 | 688,579 | Feb 09, 2021, 08:36 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 01, 2021 | Sale | $31.53 | 309,889 | 9,770,505 | 598,814 | Feb 03, 2021, 09:39 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 03, 2021 | Sale | $37.81 | 184,916 | 6,992,283 | 651,661 | Feb 03, 2021, 09:39 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Feb 01, 2021 | Sale | $27.82 | 163,659 | 4,552,523 | 121,686 | Feb 03, 2021, 09:38 PM | |
| NTLA | Intellia Therapeutics, Inc. | Cohen Fred E | Director | Jan 20, 2021 | Option Exercise | $13.78 | 20,000 | 275,600 | 30,000 | Jan 22, 2021, 04:22 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Jan 05, 2021 | Sale | $55.86 | 6,239 | 348,511 | 475,488 | Jan 05, 2021, 09:24 PM | |
| NTLA | Intellia Therapeutics, Inc. | SCHIERMEIER ANDREW | EVP, Chief Operating Officer | Jan 05, 2021 | Sale | $55.86 | 1,377 | 76,919 | 16,656 | Jan 05, 2021, 08:58 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Jan 05, 2021 | Sale | $55.86 | 2,078 | 116,077 | 51,990 | Jan 05, 2021, 08:55 PM | |
| NTLA | Intellia Therapeutics, Inc. | SCHIERMEIER ANDREW | EVP, Chief Operating Officer | Dec 30, 2020 | Option Exercise | $13.48 | 1,500 | 20,220 | 12,673 | Jan 04, 2021, 09:03 PM | |
| NTLA | Intellia Therapeutics, Inc. | KARSEN PERRY A | Director | Dec 17, 2020 | Sale | $36.00 | 177,528 | 6,391,522 | 93,764 | Dec 18, 2020, 04:29 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Dec 01, 2020 | Sale | $23.66 | 8,364 | 197,925 | 52,072 | Dec 03, 2020, 06:42 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 27, 2020 | Option Exercise | $27.37 | 70,000 | 1,916,100 | 487,352 | Nov 27, 2020, 09:00 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 25, 2020 | Option Exercise | $21.41 | 100,000 | 2,141,500 | 517,352 | Nov 25, 2020, 08:02 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 16, 2020 | Option Exercise | $24.29 | 40,000 | 971,600 | 487,352 | Nov 18, 2020, 07:56 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Nov 16, 2020 | Option Exercise | $17.20 | 16,591 | 285,313 | 52,315 | Nov 18, 2020, 07:55 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Nov 18, 2020 | Option Exercise | $25.38 | 1,472 | 37,358 | 47,696 | Nov 18, 2020, 07:55 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Nov 04, 2020 | Sale | $19.56 | 8,364 | 163,592 | 45,679 | Nov 06, 2020, 04:41 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 04, 2020 | Sale | $16.41 | 100,000 | 1,641,500 | 517,352 | Nov 06, 2020, 04:38 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Oct 15, 2020 | Sale | $13.08 | 15,615 | 204,183 | 46,294 | Oct 16, 2020, 08:58 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Oct 07, 2020 | Sale | $14.33 | 10,000 | 143,300 | 472,352 | Oct 09, 2020, 04:14 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Sep 15, 2020 | Sale | $11.94 | 15,615 | 186,440 | 41,909 | Sep 17, 2020, 04:55 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Sep 01, 2020 | Sale | $14.33 | 10,000 | 143,300 | 472,352 | Sep 03, 2020, 04:15 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Aug 18, 2020 | Sale | $11.93 | 15,615 | 186,215 | 37,524 | Aug 20, 2020, 04:13 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Aug 06, 2020 | Sale | $14.33 | 10,000 | 143,300 | 472,352 | Aug 07, 2020, 07:29 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Jul 15, 2020 | Sale | $12.54 | 15,615 | 195,761 | 33,139 | Jul 17, 2020, 04:18 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Jul 01, 2020 | Sale | $14.33 | 10,000 | 143,300 | 472,352 | Jul 02, 2020, 04:10 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | Jun 16, 2020 | Option Exercise | $11.93 | 15,615 | 186,215 | 27,897 | Jun 18, 2020, 05:00 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Jun 03, 2020 | Option Exercise | $14.33 | 10,000 | 143,300 | 472,352 | Jun 05, 2020, 05:18 PM | |
| NTLA | Intellia Therapeutics, Inc. | Rivera Jose E | EVP, General Counsel | May 26, 2020 | Option Exercise | $12.00 | 15,615 | 187,394 | 285,722 | May 28, 2020, 05:23 PM | |
| NTLA | Intellia Therapeutics, Inc. | SCHIERMEIER ANDREW | EVP, Dev and Corp Strategy | Mar 06, 2019 | Buy | $15.72 | 7,500 | 117,875 | 7,500 | Mar 12, 2019, 04:38 PM | |
| NTLA | Intellia Therapeutics, Inc. | Cohen Fred E | Director | Mar 01, 2019 | Option Exercise | $16.89 | 10,000 | 168,936 | 10,000 | Mar 05, 2019, 12:00 AM | |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Director | Jul 16, 2018 | Sale | $31.17 | 6,686 | 208,397 | 1,402 | Jul 18, 2018, 08:40 AM | |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Director | Jun 19, 2018 | Sale | $27.96 | 6,686 | 186,908 | 1,400 | Jun 20, 2018, 12:03 PM | |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Director | May 16, 2018 | Sale | $25.04 | 6,686 | 167,389 | 0 | May 17, 2018, 10:47 AM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | May 14, 2018 | Sale | $24.00 | 8,400 | 201,600 | 0 | May 15, 2018, 08:43 PM | |
| NTLA | Intellia Therapeutics, Inc. | Bell Graeme | EVP, Chief Financial Officer | Mar 28, 2018 | Option Exercise | $13.48 | 8,000 | 107,840 | 21,400 | Mar 30, 2018, 10:20 AM | |
| NTLA | Intellia Therapeutics, Inc. | DORSA CAROLINE | Director | Mar 23, 2018 | Option Exercise | $24.05 | 410 | 9,860 | 5,410 | Mar 26, 2018, 05:12 PM | |
| NTLA | Intellia Therapeutics, Inc. | FORMELA JEAN FRANCOIS | Director | Mar 20, 2018 | Sale | $23.87 | 39,245 | 936,743 | 36,628 | Mar 22, 2018, 01:43 PM | |
| NTLA | Intellia Therapeutics, Inc. | Caribou Biosciences, Inc. | 10% Owner | Jan 29, 2018 | Sale | $26.78 | 550,645 | 14,746,273 | 3,994,355 | Jan 30, 2018, 05:28 PM | |
| NTLA | Intellia Therapeutics, Inc. | NOVARTIS AG | 10% Owner | Dec 12, 2017 | Sale | $18.30 | 1,523,000 | 27,870,899 | 4,129,903 | Dec 14, 2017, 12:19 PM | |
| NTLA | Intellia Therapeutics, Inc. | Bermingham Nessan | President & CEO | Dec 06, 2017 | Sale | $20.34 | 111,500 | 2,268,001 | 696,000 | Dec 08, 2017, 05:27 PM | |
| NTLA | Intellia Therapeutics, Inc. | Bermingham Nessan | President & CEO | Dec 07, 2017 | Sale | $21.14 | 131,140 | 2,771,867 | 579,959 | Dec 08, 2017, 05:27 PM | |
| NTLA | Intellia Therapeutics, Inc. | Bermingham Nessan | President & CEO | Dec 08, 2017 | Sale | $20.82 | 94,143 | 1,960,151 | 458,250 | Dec 08, 2017, 05:27 PM |
Menu